↓ Skip to main content

Dove Medical Press

Article Metrics

Initial assessment of the benefits of implementing pharmacogenetics into the medical management of patients in a long-term care facility

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, January 2016
Altmetric Badge

Mentioned by

news
4 news outlets
twitter
12 tweeters
facebook
3 Facebook pages

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
40 Mendeley
Title
Initial assessment of the benefits of implementing pharmacogenetics into the medical management of patients in a long-term care facility
Published in
Pharmacogenomics and Personalized Medicine, January 2016
DOI 10.2147/pgpm.s93480
Pubmed ID
Authors

Juan-Sebastian Saldivar, David Taylor, Elaine Sugarman, Ali Cullors, Jorge Garces, Kahuku Oades, Joel Centeno, Elaine A Sugarman, Jorge A Garces

Abstract

The health care costs associated with prescription drugs are enormous, particularly in patients with polypharmacy (taking more than five prescription medications), and they continue to grow annually. The evolution of pharmacogenetics has provided clinicians with a valuable tool that allows for a smarter, more fine-tuned approach to treating patients for a number of clinical conditions. Applying a pharmacogenetics approach to the medical management of patients can provide a significant improvement to their care, result in cost savings by reducing the use of ineffective drugs, and decrease overall health care utilization. AltheaDx has begun a study to look at the benefits associated with incorporating pharmacogenetics into the medical management of patients who are on five or more medications. Applying pharmacogenetic guided PharmD recommendations across this patient population resulted in the elimination and/or replacement of one to three drugs, for 50% of the polypharmacy patient population tested, and an estimated US$621 in annual savings per patient. The initial assessment of this study shows that there is a clear opportunity for concrete health care savings solely from prescription drug management when incorporating pharmacogenetic testing.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 3%
Unknown 39 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 23%
Researcher 7 18%
Student > Doctoral Student 5 13%
Other 5 13%
Student > Master 4 10%
Other 7 18%
Unknown 3 8%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 16 40%
Pharmacology, Toxicology and Pharmaceutical Science 8 20%
Nursing and Health Professions 3 8%
Agricultural and Biological Sciences 3 8%
Medicine and Dentistry 3 8%
Other 1 3%
Unknown 6 15%